[Assessment of treatment adherence among black Africans with heart failure]

M P B N'Cho-Mottoh1, B Boka2, K Yayehd3

  • 1Institut de cardiologie d'Abidjan, 04 BP 64, 04 Abidjan, Côte d'Ivoire.

Insights

Heart failure patient adherence is poor in African cardiology patients, significantly impacted by traditional medicine use. Therapeutic education is vital for improving patient knowledge and treatment adherence.

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacology

Background:

  • Heart failure (HF) is a significant global health concern.
  • Patient adherence to treatment is crucial for managing HF and improving outcomes.
  • Understanding factors influencing adherence in diverse populations, such as in African cardiology departments, is essential.

Purpose of the Study:

  • To investigate patient-related factors affecting treatment adherence in heart failure patients within an African cardiology setting.
  • To identify specific influences, including traditional medicine use, on adherence to medication, follow-up, and lifestyle modifications.

Main Methods:

  • A prospective observational study conducted at the Abidjan cardiology institute.
  • Inclusion of 121 patients with chronic heart failure hospitalized for decompensated HF.
  • Utilized the revised heart failure compliance questionnaire and multiple linear regression analysis.

Main Results:

  • Overall poor adherence was observed in 88.4% of heart failure patients.
  • Use of traditional medicine was significantly associated with poor adherence in medication intake, follow-up appointments, and sodium restrictions.
  • Increased hospitalizations correlated with improved adherence, even after adjusting for demographic and other alternative medicine factors.

Conclusions:

  • Adherence to heart failure treatment remains a significant challenge in Black African populations.
  • Traditional medicine use is a key factor negatively impacting adherence.
  • Enhanced therapeutic education is critical to improve patient understanding and adherence to heart failure management.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
547
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
520
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
692
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.1K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
579